[$$] AstraZeneca: FDA Approves Myalept for Leptin Deficiency Treatment

[$$] AstraZeneca: FDA Approves Myalept for Leptin Deficiency Treatment

[at The Wall Street Journal] – Vodafone’s exploration of acquisitions of cable assets in Europe is complicating a possible deal with AT&T, people familiar with the matter said. more

View todays social media effects on NWSA

View the latest stocks trending across Twitter. Click to view dashboard

See who News is hiring next, click here to view

Share this post